Research programme: therapeutics - Shiner Pharm

Drug Profile

Research programme: therapeutics - Shiner Pharm

Alternative Names: Product AL; Product BH; Product EM; Product GX; Product IM; Product MP; Product OX; Product QF; Product RI; Product RII; Product SC; Product TE; Product TH; Product TL

Latest Information Update: 11 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shiner Pharm Corp
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase Unknown Cancer; Digestive system disorders; Neurological disorders; Osteoporosis

Most Recent Events

  • 11 Feb 2016 Investigation in Cancer in Taiwan (unspecified route)
  • 11 Feb 2016 Investigation in Digestive system disorders in Taiwan (unspecified route)
  • 11 Feb 2016 Investigation in Neurological disorders in Taiwan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top